Biomerica (BMRA) Net Margin (2010 - 2026)

Biomerica (BMRA) reported Net Margin of 132.93% for Q1 2026, down 2900.0% on a YoY basis from 4.75% in Q1 2025, and down 21.85% sequentially from 109.09% in Q4 2025.

Biomerica (BMRA) Net Margin (2010 - 2026) Analysis & Trends

Biomerica (BMRA) has 17 years of Net Margin data on file, last reported at 132.93% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 2900.0% year-over-year to 132.93%; the trailing twelve-month figure through Feb 2026 stood at 96.44% (down 1437.0% YoY), and the FY2025 full-year result was 93.6%, up 1329.0% from the prior year.
  • Net Margin eased to 132.93% in Q1 2026, from 109.09% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.14% in Q3 2025 to a low of 209.75% in Q2 2023.
  • A 5-year average of 104.28% and a median of 109.09% in 2025 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin jumped 27603 bps in 2022 and plunged 17657 bps in 2023, its largest moves.
  • Tracing BMRA's Net Margin over 5 years: stood at 109.72% in 2022, then rose by 12 bps to 96.17% in 2023, then jumped by 40 bps to 58.07% in 2024, then slumped by 88 bps to 109.09% in 2025, then decreased by 22 bps to 132.93% in 2026.
  • Business Quant data shows BMRA's Net Margin at 132.93% in Q1 2026, 109.09% in Q4 2025, and 0.14% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 183.17 Bn 175.87 Bn 6.27 Bn 9.65%
2 Stryker 129.06 Bn 126.18 Bn 3.81 Bn 12.38%
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn 12.84%
4 Boston Scientific 68.56 Bn 67.10 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 48.33 Bn 44.66 Bn 1.29 Bn -
6 Dexcom 28.38 Bn 27.26 Bn 750.30 Mn 16.74%
7 GE HealthCare Technologies 28.08 Bn 25.80 Bn 1.98 Bn 8.01%
8 Smith & Nephew 26.93 Bn 26.36 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn 3.87%
10 Biomerica 4.88 Mn 3.54 Mn -44,000.00 -132.93%

Historic Data

Download Data
DateValue
Feb 28, 2026 -132.93%
Nov 30, 2025 -109.09%
Aug 31, 2025 0.14%
May 31, 2025 -205.87%
Feb 28, 2025 -103.93%
Nov 30, 2024 -58.07%
Aug 31, 2024 -72.83%
May 31, 2024 -110.30%
Feb 29, 2024 -188.59%
Nov 30, 2023 -96.17%
Aug 31, 2023 -66.08%
May 31, 2023 -209.75%
Feb 28, 2023 -148.51%
Nov 30, 2022 -109.72%
Aug 31, 2022 -126.57%
May 31, 2022 -33.18%
Feb 28, 2022 -1.36%
Nov 30, 2021 -24.22%
Aug 31, 2021 -122.23%
May 31, 2021 -309.21%